| abstract |
A method of treating vascular leakage syndrome and cancer is provided. The present disclosure provides a method of treating a patient with vascular leakage syndrome, the method administering to the patient a composition comprising an effective amount of a β-ECD binding agent or a pharmaceutically acceptable salt thereof. Including doing. The present disclosure provides a method of treating vascular leakage, wherein the patient being treated suffers from an inflammatory disease or condition, trauma, shock, adult respiratory distress syndrome, acute lung injury or sepsis, the method comprising the patient Administering an effective amount of a β-ECD binding agent or a pharmaceutically acceptable salt thereof. [Selection figure] None |